NO923266L - Heksahydrobenzo(f)quinolinoner - Google Patents
Heksahydrobenzo(f)quinolinonerInfo
- Publication number
- NO923266L NO923266L NO92923266A NO923266A NO923266L NO 923266 L NO923266 L NO 923266L NO 92923266 A NO92923266 A NO 92923266A NO 923266 A NO923266 A NO 923266A NO 923266 L NO923266 L NO 923266L
- Authority
- NO
- Norway
- Prior art keywords
- hexahydrobenzo
- quinolinoner
- quinolin
- steroid
- alpha
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
- C07D215/06—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms having only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
- C07D221/10—Aza-phenanthrenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US74813491A | 1991-08-21 | 1991-08-21 | |
| US07/780,166 US5250539A (en) | 1991-08-21 | 1991-10-21 | Hexahydrobenzo[f]quinolinones |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO923266D0 NO923266D0 (no) | 1992-08-20 |
| NO923266L true NO923266L (no) | 1993-02-22 |
Family
ID=27114886
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO92923266A NO923266L (no) | 1991-08-21 | 1992-08-20 | Heksahydrobenzo(f)quinolinoner |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5250539A (no) |
| EP (1) | EP0531026B1 (no) |
| JP (1) | JPH05213889A (no) |
| KR (1) | KR930004269A (no) |
| CN (1) | CN1069488A (no) |
| AT (1) | ATE173467T1 (no) |
| AU (1) | AU2118292A (no) |
| BR (1) | BR9203266A (no) |
| CA (1) | CA2076509A1 (no) |
| CZ (1) | CZ256792A3 (no) |
| DE (1) | DE69227612T2 (no) |
| FI (1) | FI923751A (no) |
| HU (1) | HUT68064A (no) |
| IL (1) | IL102880A0 (no) |
| MX (1) | MX9204815A (no) |
| NO (1) | NO923266L (no) |
| TW (1) | TW218011B (no) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU654573B2 (en) * | 1991-08-21 | 1994-11-10 | Eli Lilly And Company | Benzo(f)quinolinones |
| US5239075A (en) * | 1991-08-21 | 1993-08-24 | Eli Lilly And Company | Process for the preparation of benzo (f) quinolinones |
| GB9317314D0 (en) * | 1993-08-20 | 1993-10-06 | Smithkline Beecham Corp | Compounds |
| US5578724A (en) * | 1994-09-20 | 1996-11-26 | Eli Lilly And Company | Process for preparation of benzo[f]quinolinones |
| FR2737721B1 (fr) | 1995-08-08 | 1997-09-05 | Roussel Uclaf | Nouveaux composes biphenyles, leur procede de preparation et les intermediaires de ce procede, leur application a titre de medicament et les compositions pharmaceutiques les contenant |
| EP0926148A1 (en) * | 1997-12-23 | 1999-06-30 | Applied Research Systems Ars Holding N.V. | Benzo (C)quinolizine derivatives, their preparation and use as 5-alphareductases inhibitors |
| GB0222516D0 (en) * | 2002-09-27 | 2002-11-06 | Karobio Ab | Novel compounds |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0102046A1 (en) * | 1982-08-26 | 1984-03-07 | Schering Corporation | Tricyclic lactams, method for making them, pharmaceutical compositions containing them |
| US4511569A (en) * | 1982-08-26 | 1985-04-16 | Schering Corporation | Tricyclic lactams and derivatives useful in increasing cardiac contractility |
| US4859681A (en) * | 1984-02-27 | 1989-08-22 | Merck & Co., Inc. | 17 α-Acyl-4-aza-5a-androst-1-en-3-ones as 5 alpha-reductase inhibitors |
| US5120742A (en) * | 1984-02-27 | 1992-06-09 | Merck & Co., Inc. | 17 β-acyl-4-aza-5 α-androst-1-ene-3-ones as 5 α-reductase inhibitors |
| FI82931C (fi) * | 1986-01-23 | 1991-05-10 | Hoffmann La Roche | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara bensazecinderivat. |
| US4888336A (en) * | 1987-01-28 | 1989-12-19 | Smithkline Beckman Corporation | Steroid 5-alpha-reductase inhibitors |
| US4980372A (en) * | 1987-05-11 | 1990-12-25 | Ono Pharmaceutical Co., Ltd. | Benzoylaminophenoxybutanoic acid derivatives |
| IN167395B (no) * | 1987-07-21 | 1990-10-20 | Hoffmann La Roche | |
| US5120840A (en) * | 1990-08-01 | 1992-06-09 | Merrell Dow Pharmaceuticals Inc. | 4-amino-4-ene-steroids and their use as 5α-reductase inhibitors |
-
1991
- 1991-10-21 US US07/780,166 patent/US5250539A/en not_active Expired - Fee Related
-
1992
- 1992-08-19 HU HU9202710A patent/HUT68064A/hu unknown
- 1992-08-20 IL IL102880A patent/IL102880A0/xx unknown
- 1992-08-20 JP JP4221358A patent/JPH05213889A/ja active Pending
- 1992-08-20 EP EP92307636A patent/EP0531026B1/en not_active Expired - Lifetime
- 1992-08-20 NO NO92923266A patent/NO923266L/no unknown
- 1992-08-20 CZ CS922567A patent/CZ256792A3/cs unknown
- 1992-08-20 CN CN92109570A patent/CN1069488A/zh active Pending
- 1992-08-20 FI FI923751A patent/FI923751A/fi not_active Application Discontinuation
- 1992-08-20 AU AU21182/92A patent/AU2118292A/en not_active Abandoned
- 1992-08-20 MX MX9204815A patent/MX9204815A/es unknown
- 1992-08-20 DE DE69227612T patent/DE69227612T2/de not_active Expired - Fee Related
- 1992-08-20 CA CA002076509A patent/CA2076509A1/en not_active Abandoned
- 1992-08-20 KR KR1019920014993A patent/KR930004269A/ko not_active Application Discontinuation
- 1992-08-20 AT AT92307636T patent/ATE173467T1/de not_active IP Right Cessation
- 1992-08-21 BR BR929203266A patent/BR9203266A/pt not_active Application Discontinuation
- 1992-09-25 TW TW081107628A patent/TW218011B/zh active
Also Published As
| Publication number | Publication date |
|---|---|
| AU2118292A (en) | 1993-02-25 |
| DE69227612T2 (de) | 1999-05-06 |
| US5250539A (en) | 1993-10-05 |
| MX9204815A (es) | 1993-12-01 |
| FI923751A (fi) | 1993-02-22 |
| IL102880A0 (en) | 1993-01-31 |
| CN1069488A (zh) | 1993-03-03 |
| FI923751A0 (fi) | 1992-08-20 |
| CA2076509A1 (en) | 1993-02-22 |
| EP0531026A1 (en) | 1993-03-10 |
| DE69227612D1 (de) | 1998-12-24 |
| HUT68064A (en) | 1995-05-29 |
| CZ256792A3 (en) | 1993-04-14 |
| TW218011B (no) | 1993-12-21 |
| EP0531026B1 (en) | 1998-11-18 |
| NO923266D0 (no) | 1992-08-20 |
| BR9203266A (pt) | 1993-04-06 |
| ATE173467T1 (de) | 1998-12-15 |
| JPH05213889A (ja) | 1993-08-24 |
| KR930004269A (ko) | 1993-03-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT589843E (pt) | Composicoes farmaceuticas contendo ciclosporinas | |
| EE03177B1 (et) | Heterobitsüklilised ühendid, nende saamismeetod ja nimetatud ühendeid sisaldavad farmatseutilised kompositsioonid | |
| ITRM920361A1 (it) | Composizioni farmaceutiche contenenti un composto allilamminico quale principio attivo. | |
| DE298196T1 (de) | Imidazol-verbindung und diese enthaltende biozide zusammensetzungen. | |
| NO965377D0 (no) | Indolinonforbindelser samt farmasöytiske preparater inneholdende forbindelsene | |
| IL128425A0 (en) | Taxane derivatives their preparation and pharmaceutical compositions containing them | |
| ITBO910113A1 (it) | Formulazioni farmaceutiche per uso orale gastroresistenti contenenti acidi biliari. | |
| DE69313134D1 (de) | Adjuvantien enthaltende impfstoffzusammensetzung | |
| IL105715A0 (en) | 7beta substituted-4-aza-5alpha-androstan-3-ones and pharmaceutical compositions containing them | |
| MX9203099A (es) | N-heterociclico-n-(4-piperidia)amidas y composiciones farmaceuticas y metodos que emplean dichos compuestos. | |
| GR1000118B (el) | Συνθεσις 1,2-διοξετανων & ενδιαμεσαι ουσιαι δι αυτην. | |
| IL105717A0 (en) | 7beta substituted-4-aza-5alpha-cholestan-3-ones and pharmaceutical compositions containing them | |
| IT1231012B (it) | Composizione farmaceutica per uso orale contenente nac. | |
| IT8820386A0 (it) | Composizioni farmaceutiche orosolubili contenti acetilcisteina. | |
| ITMI921123A0 (it) | Formulazioni farmaceutiche orali contenenti antocianosidi | |
| MX9203505A (es) | N-aril-n-(4-(1-alquilheterociclico)-piperidinil) amidas y composicines farmaceuticas y metodos que emplean dichos compuestos. | |
| NO923266L (no) | Heksahydrobenzo(f)quinolinoner | |
| DE69300492D1 (de) | Orale Zusammensetzung. | |
| TR27833A (tr) | Antelmintik'lerin uygulanmasina mahsus ''pour-on'' formülasyonu. | |
| AU1174588A (en) | Anticonvulsant agents | |
| HUP9900863A3 (en) | 4,4-(disubstituted)cyclohexan-1-ol derivatives pharmaceutical compositions containing these compounds and use thereof | |
| ITMI913510A1 (it) | Composizioni farmaceutiche contenenti progesterone ad elevata biodisponibilita' | |
| AR008474A1 (es) | Derivado de 9-dihidroeritromicina a 6,9; 11,12-diciclocarbonato, composicion farmaceutica y preparacion bactericida que lo contienen y su uso | |
| FR2677250B1 (fr) | Compositions pharmaceutiques contenant de l'adenosine-5-triphosphate disodique. | |
| DE69614552T2 (de) | MODIFIZIERTE ALPHA-D-GLCP-(1,2)-ALPHA-D-Glcp-(1,3)-ALPHA-D-Glcp-ANALOGE |